The toxins could potentially be used as ‘markers’ for doctors to identify Parkinson’s patients at a higher risk of developing ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

Scientists have imaged and quantified the toxic protein molecules that are thought to drive Parkinson’s disease for the first ...

Researchers have identified gene activity changes in immune cells from blood samples that could enable early, non-invasive ...

Researchers have finally seen and measured the tiny alpha-synuclein oligomers that may ignite Parkinson’s disease. With the ...

We've already seen a pen that helps people with Parkinson's disease to write clearly, but this one is a little different. By assessing its user's hand movements as they write, it can provide an early ...

- Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson’s disease - - Prasinezumab is a potential ...

Most Parkinson's symptoms stem from the loss or dysfunction of dopamine-producing neurons in a brain region involved in fine ...

Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled ...

The world's largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt ...